Dimension
New York City, New Yorkdimensioncap.com
Overview
Dimension is an early-stage venture capital firm founded in 2022 that invests in companies at the intersection of technology and life sciences, including biotechnology platforms, software, and AI-driven drug discovery.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Chai Discovery | Jul 2026 | Series C | Lead |
| Earendil | Mar 2026 | VC Round | Lead |
| Congruence Therapeutics | Mar 2026 | VC Round | Lead |
| Automata | Jan 2026 | Series C | Lead |
| BioRender | Dec 2025 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.